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Abstract 
Cellular autophagy (Macrophagy) is a self-degradative process, executed through the 
network of autophagy associated genes (ATGs) encoded proteins. Both in vitro and in vivo 
studies suggest that dengue virus (DENV) induces autophagy and supports the viral genome 
replication and translation. Therefore, the cellular autophagy induced by dengue virus can be 
a good target for antiviral drug development. The action of mycophenolic acid (MPA), a 
specific inhibitor of DENV replication, was investigated in the stable BHK-21/DENV2 
replicon cells. The inhibition was mediated by enhanced degradation of autophagic substrates 
in stable BHK-21/DENV2 replicon cells as evidenced by a decrease in lapidated LC3 (LC3II) 
and p62 expression in the presence of MPA. In contrast, the results indicated that four gene 
sets, namely Trans membrane protein 74 (TMEM74), Unc-51-like kinase 2 (ULK2), 
Cathepsin D (CTSD) and Estrogen receptor 1 (ESR1) were upregulated in stable BHK-
21/DENV2 replicon cells, due to the sustained dynamic replication of DENV2 genome. 
These ATGs involved in the pre-autophagosomal structure (PAS) formation, were suppressed 
in the presence MPA.  Instead, MPA induced the expression of different set of autophagy 
genes such as ATG4, AKT1, APP, ATG16L1, ATG16L2, B2M and HPRT1. An enzyme 
involved in the nucleotide salvage pathway, HPRT1, was highly expressed in the presence of 
MPA. The study shows that DENV2 replication is dependent on PAS formation and is 
inhibited in the presence of MPA by enhancing the degradation of autophagic substrates and 
suppression of PAS formation.  This study provides impetus in designing MPA analogues to 
effectively inhibit dengue viral replication.  
Key words: dengue; autophagy; viruses; replicon ; MPA; replication, LC3 II, p62. 
Abbreviations: ATG, autophagy; ATGs, autophagy associated genes; BHK, baby hamster kidney 
cells; oC, degree centigrade; C, capsid protein; cDNA, complementary deoxyribonucleic Acid; cm,  
centimeter;  CO2, carbon dioxide;  DENV 2, dengue virus type-2; DENV 3, dengue virus type 3; 
DENV 4,  dengue virus type 4; DENV1, dengue virus type 1; DENV, dengue virus; DMEM, 
Dulbecco's modified eagle medium; EDTA, Ethylene diamine tetra Acetic acid;  E, Envelope protein; 
ELISA,  Enzyme-Linked Immunosorbent Assay; ER, Endoplasmic reticulum; FBS, Fetal Bovine 
Serum; G, gram; G418, geneticin; HCV, Hepatitis C virus; IRES, internal ribosome entry site ; IVT, 
In vitro transcription; kb, kilobase pairs; LC3 II, light chain 3 form II of the microtubule-associated 
protein 1; LC3, light chain 3; mg, milligram; ml, milliliter; mm, millimeter; MPA, mycophenolic acid; 
MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5 –diphenyl tetrazolium bromide);  mRNA, messenger 
RNA;  NGC, New Guinea C strain; nm, nanometer; NS1, non-structural protein 1; NS, non-structural; 
O.D, Optical Density;  ORF, open reading frame; p62, SQSTM1; PCR, Polymerase Chain Reaction;  
p, pearson coefficient; RNA, ribonucleic acid; RT PCR, reverse transcription-polymerase chain 
reaction; RT, room temperature;  UTR, untranslated region. 
 
3 
 
1. Introduction  
Dengue is a major public health concern that causes severe morbidity and mortality, 
especially in tropical and subtropical countries. Dengue fever is an Aedes mosquito vector-
borne ailment caused by any one of four serotypes of dengue virus (DENV 1 to 4) (1). DENV 
genome consists of a single positive-strand RNA and replicates efficiently in the 
Endoplasmic Reticulum (ER) of the infected cells by hijacking host autophagy machinery 
(2). Autophagy is an evolutionarily conserved protective mechanism that is induced during 
DENV infection. It is involved in shuttling the damaged cellular cargo to lysosomes for 
degradation and recycling (3). This complex process is coordinated by proteins encoded by 
the autophagy-associated genes (ATGs) (4). Autophagy is required for optimal RNA 
replication of DENV (5, 6) and the infection could induce autophagy in in vivo models (7).  
          RNA viruses such as DENVs induce autophagy to get supportive benefits for their 
replication using ER membrane scaffolds (8). DENV infection causes ER membrane 
remodeling in an infected cell, controlled by a large number of autophagic proteins and its 
upstream/ downstream signaling molecules. Autophagy genes play antiviral and/or proviral 
role in the life cycle and pathogenesis of many different viruses (9). Also, it was observed 
that the autophagy helps to maintain homeostatic environment in DENV infected cells and 
favors for the production of virions (10, 11). The RNA viruses subvert autophagy machinery 
to establish its replication within the host cells (8). DENV utilizes autophagy to foster its 
cellular growth and non-lytic cellular egress (12). Many postulates suggest that inhibition of 
autophagy might reduce the viral replication by reducing number of virions and protection 
from cellular apoptosis (13). 
Inhibitors such as Bafilomycin A1, Chloroquine, and Pepstatin A/E64d inhibit degradation of 
the autolysosome contents via inhibition of the Na+/H+ pump at the lysosome, increasing 
lysosomal pH and inhibiting acidic lysosomal proteases, respectively. The earlier studies 
have shown that the nucleoside analogues such as 2'-C-methyladenosine (EC50=2.42 +/- 0.59 
µM), and antiviral drugs like Ribavirin (EC50=6.77 +/- 1.33 µM), and MPA (EC50=1.31 +/- 
0.27 µM) can effectively inhibit DENV replication (14, 15). MPA inhibits DENV genome 
replication, antigen expression, and maturation (16). The proposed mechanism of MPA 
action suggests that it inhibits Inosine monophosphate dehydrogenase (IMPD) enzyme and 
thereby cause depletion of the intracellular Guanosine-5'-triphosphate (GTP) pool (15). 
Although, some progress has been made in understanding how autophagy genes are regulated 
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by dengue viral replication during infection (9), very little is known on the identity of specific 
dengue viral proteins involved in the host autophagy induction and maturation. It is also not 
clear whether DENV induces the autophagy at an early stage or later stage (egress) of virus 
life cycle. 
            Baby Hamster Kidney (BHK-21) cells are permissive cellular model for many viruses 
including DENV (17). Therefore, we sought to investigate the autophagy related gene (ATG) 
expression in stable BHK-21/DENV2 replicon cells. The subgenomic replicon encodes 
DENV2  non-structural genes involved in the dengue viral replication. The stable replicon 
system is broadly used in the studies of trans-complementation, adaptive mutation, viral 
assembly and packaging of Kunjin, Yellow fever and West Nile viruses (14). In the present 
study, we investigated the effect of MPA on the modulation of host autophagy gene 
expression during dengue virus RNA replication in stable BHK 21/DENV2 replicon cells 
along with assessment of the degradation of autophagic substrates such as LC3 and p62.  
2. Materials and Methodology 
2.1 Cells 
Baby Hamster Kidney (BHK-21) cells were procured from National Centre for Cell 
Science, Pune, India. Dulbecco’s modified Eagle medium (Himedia; catalogue#AT149), FBS 
(Life Technologies; catalogue#10439-016), L- Glutamine (Sigma; catalogue#G7513), 
Penicillin-Streptomycin (Sigma; catalogue#P4333), mycophenolic acid (Sigma; 
catalogue#M5255) an inhibitor of  DENV-RNA replication, were procured from the supplier 
(Sigma-Aldrich®). The cells were cultured and maintained at 37oC with 5% CO2 incubator 
(Thermo Scientific™ Forma™ Steri-Cycle i160). 
The pRS424 plasmid containing frame work of non-structural genes of DENV 2 
(NGCstrain) was a kind gift from Prof. Padmanabhan's laboratory (Georgetown University, 
Washington DC, USA). The pRS424 plasmid containing coding regions (RLuc-IRES-Neor-
DENV2-NS) were cloned downstream of SP6 promoter. The gene order of replicon is 5’ 
UTR, N terminal coding sequence of capsid (C), Renilla Luciferase reporter (Rluc) with 
translational termination codon and internal ribosome entry site (IRES) for 5’-cap-
independent translation of the downstream ORF that encodes a poly protein precursor C 
terminus E-NS1-NS2A, NS2B, NS4A, NS4B, NS5 followed by 3’ UTR. 
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2.2 In Vitro Transcription (IVT) of DENV2 subgenomic replicon cDNA  
The pRS424 plasmid encoding DENV2 replicon cDNA was propagated in Stbl2 
competent cells (Thermo Fisher Scientific; catalogue #10268019) and was linearized by Sac I 
restriction enzyme digestion and purified with PCR purification kit (Thermo Fisher 
Scientific; catalogue #K310001). Further, the linearized plasmid was used as a template for in 
vitro RNA synthesis and DENV 2 subgenome was transcribed by SP6 polymerase using in 
vitro transcription kit (MEGA script; AM1330, Invitrogen) as per the manufacturer’s 
instructions. Finally IVT-RNA was prepared. 
2.3 Transfection of IVT-RNA into naïve BHK-21 cells and generation of stable BHK-
21/DENV2 replicon cells  
The newly synthesized IVT-RNA was resolved on agarose gel (2%) and purified from 
the gel as per the instructions of gel purification kit (Qiagen, catalogue # 28704). The gel 
purified RNA was transfected into naïve BHK-21 cells using transfection kit (Mirus Bio 
Trans IT-mRNA; MIR 2225). The transfected BHK 21 cells were grown in DMEM 
containing Geneticin (G418) selectable marker. Finally the resistant, stable BHK-21/DENV2 
clones were selected under G418 selection at the concentration of  400 µg/ml. The stable 
BHK 21 replicon cells were maintained at (37 ± 1) °C in 5% CO2 in 50-60% confluence by 
sub culturing  every 3-4 days.  
2.4 Characterization of  stable BHK-21/DENV2 replicon cells 
2.4.1 DENV2- NS4A gene amplification by Reverse Transcriptase PCR (RT-PCR) 
Total RNA was isolated from the stable BHK-21/DENV2 replicon cells as well as 
naive BHK-21 cells using TRIzolTM reagent (Invitrogen, catalogue#15596018). The reverse 
transcriptase enzyme was added to the purified RNA (1µg concentration) and the mixture 
was incubated at 42oC for 15 minutes and 95oC for 5 minutes to convert total RNA into 
cDNA in an independent reactions as per RT-PCR kit manufacturer’s instruction (Qiagen 
Ltd, West Sussex, UK;, catalogue #205311). DENV2- NS4A gene was amplified under the 
conditions of initial denaturation at 94oC for 2 minutes and 35 cycles of denaturation at 94oC 
for 30 seconds, annealing at 53oC for 30 seconds and elongation at 72oC for 60 seconds and 
final extension of 72oC for 7 minutes from cDNA of respective samples by specific DENV2-
NS4A sense and anti sense primers. The amplified DNA fragments were resolved and 
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confirmed on agarose gel (2%). As an internal control Beta actin gene transcript was 
amplified by RT-PCR. 
2.4.2 Renilla luciferase (RLuc) enzyme assay 
The stable BHK-21/DENV2 replicon cells were incubated in the presence of 1.25µM 
MPA for 24 hours. Renilla luciferase (RLuc) enzyme activities in 20 µL stable BHK-
21/DENV2 replicon cell lysate (untreated group) and MPA-treated stable BHK-21/DENV2 
replicon cell lysate (treated group) were quantified independently by RLuc enzyme assay. 
The assay was performed in three independent experiments (n=3). The experimental 
procedure was performed as per the manufacturer's instructions (Promega Corporation, 
Madison, WI, USA; catalogue #E2810). RLuc enzyme activities were measured in the cell 
lysates and the statistical analysis was used to assess the difference between the untreated 
group (without drug) and treated group (with the drug). The difference in RLuc enzyme 
activity in treated versus untreated group is detected by luminescence signals in a multimode 
plate reader (PerkinElmer, part number#2300-000M). The values were submitted to t- test 
and the bar diagram was made using graph pad prism software, version 5.0. The values of 
p<0.05 were considered statistically significant. 
2.4.3 Detection of the secreted DENV2- NS1 protein by ELISA 
 The stable BHK-21/DENV2 replicon cells were incubated in the presence of 1.25µM 
MPA for 24 hours. The presence of secreted DENV2- NS1protein in 100 µl culture 
supernatant of stable BHK-21/DENV2 replicon cell (untreated group) and MPA- treated 
stable BHK-21/DENV2 replicon cells ( treated group) was examined independently (n=3) by 
DENV2- NS1 micro ELISA detection kit (J. Mitra & Co, India). The kit is based on a single-
step sandwich immunoassay to detect DENV2- NS1 protein in cell culture supernatant. The 
kit contains monoclonal antibody coated on micro wells, which can detect dengue viral NS1 
protein. Normal DMEM used as mock control and standard NS1protein used as a positive 
control (provided with the kit). The optical density (O.D) of DENV2-NS1 protein was 
measured spectophotometrically at 450nms in the above culture supernatants of treated and 
untreated group. The values were submitted to t- test and bar graph was plotted using graph 
pad prism software, version 5.0. The values of p<0.05 were considered statistically 
significant. 
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2.5 Assessment of the effect of MPA on autophagic flux in stable BHK-21/DENV2 replicon 
cells    
2.5.1 Cytotoxic effect of MPA by MTT assay 
 The stable BHK-21/DENV2 replicon cells were seeded in 96-well flat-bottomed plate 
(Nunc, Nunclon™ Surface Roskilde, Denmark) @ 1x104 cells per well in DMEM with 10% 
FBS. The cells were exposed to MPA range from 0 to 5 µM for 24hours. The cytotoxic effect 
of MPA on stable BHK-21/DENV2 replicon cells was determined using MTT (Sigma-
Aldrich; catalogue# CT01-5) assay by adding 20 µl of MTT (5mg/ml) reagent to each well. 
The cells were incubated for 4 hours at 37 °C in 5% CO2. Then, DMEM containing MTT was 
removed from the wells and newly formed Formazan crystals were dissolved in 100µl 
Dimethyl sulfoxide (DMSO). Within 30 minutes, the absorbance was measured at 570 nm 
using Enspire multimode micro plate reader (Perkin Elmer). The cell viability (%) of stable 
BHK-21/DENV2 replicon cells as well as MPA treated cells was calculated. The optimum 
concentration of MPA was determined by plotting the dose response curve. 
2.5.2 Total cellular RNA isolation 
 Total cellular RNA was extracted from stable BHK-21/DENV2 replicon cells 
(Group1), MPA treated cells (Group 2) and control group (Naïve BHK-21 cells) using 
RNeasy mini kit (Qiagen, catalogue#74106). The genomic DNA contamination was removed 
from the samples by treating with RNase-free DNase (provided with kit) for 15 minutes at 
room temperature. The concentration of RNA was measured by a UV Vis spectrophotometer 
(NanoDrop 2000, Thermo Fisher, USA). The presence of RNA was confirmed on 2% agarose 
gels. 
2.5.3 cDNA synthesis and confirmation 
 The cellular RNA was used as a template for complementary DNA (cDNA) synthesis 
using RT-PCR kit as per the manufacturer (Qiagen, catalogue#205310). The cDNA was 
synthesized by incubating at 25°C for 10 minutes, 42°C for 60 minutes and at 70°C for 15 
minutes. The concentration of each cDNA prepared from Group 1, Group 2 and control group 
were measured using UV Vis spectrophotometer. The PCR amplified products were 
confirmed on 1% agarose gel. The beta actin gene amplified product was used as an internal 
control. 
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2.5.4 Autophagy gene expression analysis by quantitative real time RT-PCR 
The human RT2 Profiler PCR array plates (PAHS-084Z, from SABiosciences, USA) in 
96-well format were used for the analyzing the expression of 84 autophagy genes in a 
separate array plates in stable BHK-21/DENV2 replicon cells, MPA-treated stable BHK-
21/DENV2 replicon cells and control group. Each gene was analyzed in duplicate for each 
group (total six array plates). Using RT2 profiler kit, one  µg  of total RNA obtained from the 
above was treated with genomic DNA elimination mixture (provided with kit) by incubating 
at 45oC for 5 minutes. The reaction mixture was incubated at 42oC for 15 minutes and then 
95oC for 5 minutes to convert RNA into cDNA(30) . For each plate the master mix was 
prepared as per the manufacturer’s instructions and 25 µL reaction volume was loaded in 
each well of 96 well plate. The real time RT-PCR was performed using RT2 PCR SYBR 
Green master mix. The array plate was covered with seal and kept in Light cycler 480 (Roche 
Diagnostics Ltd, Burgess Hill, UK) and the program was set up according to manufacturer’s 
instructions.  
The relative expression ratio (R) of target genes normalized with control group in both 
stable BHK-21/DENV2 replicon cells (Group 1) and MPA treated stable BHK-21/DENV2 
replicon cells (Group 2) were calculated. The amplification data (fold changes in the 
threshold cycle (Ct) values of all the genes) was analyzed by the ∆∆Ct method for 
determining gene expression changes with the following formula: R=2∧CT(target)/2∧CT(ref), 
with CT(target) = (CT target - CT control) of target genes and CT(ref) = (CT ref - CT 
control) of internal control genes. After finishing the last cycle, the melt curve (Tm) was 
performed at 60oC, 15 s and 95oC continuous mode.  
2.5.5  Statistical analysis of q RT-PCR data 
The  fold changes in the Ct value of all the genes were grouped into 3 sets: stable BHK-
21/DENV2 replicon cells (Group 1) and MPA treated BHK-21/DENV2 replicon cells (Group 
2) and control group (Naïve BHK -21 cells) . The Ct values of all the genes were entered in 
Microsoft excel spreadsheet and analyzed by SA Biosciences web-based software 
(http://pcrdataanalysis.sabiosciences.com/pcr/ arrayanalysis.php). The experimental results 
were calculated based on Quality control (QC) performance of housekeeping gene expression 
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and statistical analysis. The changes in the gene expression levels were considered 
statistically significant with 35 PCR cycles (cut off value).  
2.5.6. Western blot analysis of LC3 and p62 (Sequestosome 1) in the stable BHK-
21/DENV2 replicon cells 
The stable BHK-21/DENV2 replicon cells were cultured @ 5X105 cells in 60 mm dish 
supplemented DMEM with 10% FBS and incubated overnight at 37 °C in a CO2 incubator. 
The cells were treated with 1.25 µM of MPA for 24hours. The stable BHK-21/DENV2 
replicon cells without exposure to MPA was used as control. After the incubation, protein 
extracts were isolated from each group of cells using RIPA protein lysis buffer containing 
1mM PMSF. Twenty microgram protein was separated on gel by10% SDS-PAGE, 
transferred with polyvinylidene difluoride membrane (Merck; IPVH00010), blocked in 5% 
BSA (Sigma, catalogue#A1470) and probed independently with specific anti-LC3 
(rabbit)(Thermo scientific; catalogue#710014), anti-P62 (mouse)(Abcam, catalogue# 
ab56416) and mouse anti β-actin (Thermo scientific, catalogue#MA5-15739) antibodies 
against the target proteins. These were followed by incubation with corresponding Goat anti-
Rabbit IgG (Sigma, catalogue# A9169), anti-mouse IgG (Sigma; catalogue#A9044) 
conjugated with HRP in separate set of experiments. Then the membrane was developed by 
adding the chemiluminescent WesternBright ECL developer (Advansta, catalogue# K-12045-
20) and the images were captured using with LI-COR C-DiGit Chemiluminescent Western 
Blot Scanner (31).The intensities of the protein bands were compared and analyzed using 
Image studio software (LiCor,C-Digit scanner). For all analysis, values of P < 0.05 were 
considered statistically significant. 
2.6 Effect of MPA on in vitro DENV2 infection  
2.6.1 Treatment of MPA in DENV2 infected BHK-21 cells 
The BHK-21 cells were plated (@ 1 × 105 cells per well in 12 well tissue culture plates in 
DMEM with 10% FBS and incubated overnight at 37 °C in a CO2 incubator. On day-0, the 
media from the wells were aspirated and further infected with DENV2 (NGC strain passage 
over C6/36 cell line) @ 1 MOI in 400 µl of DMEM with 2% FBS and incubated for 1 hour at 
37 °C inside CO2 incubator, with mild rocking at 15 minutes intervals. After the incubation, 
the DENV2 inoculum was aspirated out and 2 mL DMEM was added per well. Subsequently, 
various MPA drug dosages (0.078 to 5.0 µM) were added to the wells . The drug diluent, 
Dimethyl sulfoxide (DMSO) was used as the control treatment.  The plates were then 
incubated overnight at 37 °C in CO2 incubator for 24 hours. On day-1, 100 µl of FBS was 
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added to the wells to make up 5% concentration and the incubation was continued. At the end 
of day-2, the culture media from wells were aspirated into 2 mL eppendorf tubes and 
centrifuged at 400 xg for 10 minutes to remove the cell debris. The supernatants from 
different dosage treatments were transferred into fresh tubes and stored at -80 °C until the 
plaque assays were done. 
2.6.2 Plaque assay 
2 X 105 BHK-21 cells per well were plated in 24 well tissue culture plates in DMEM with 
10% FBS. The plates were incubated overnight at 37 °C in CO2 incubator to reach 100% 
confluent monolayer. The following day, DENV2 containing cell culture supernatants, from 
MPA dosage experiment, were serially diluted from 10-1 to 10-5 in serum free DMEM 
medium.  The culture medium from each well was removed and the BHK-21 monolayer was 
washed with serum free DMEM to remove traces of serum. Further, 200 µl of DENV2 serial 
dilutions of respective samples were added over the cells in the pre-designated wells. The 
plates were incubated for 1 hour at 37 °C inside CO2 incubator with mild rocking of plates at 
every 15 minutes intervals. 
At 1 hour post-incubation, the virus dilutions were removed and the wells were washed with 
serum free DMEM. Subsequently, 0.5 mL of overlay medium (DMEM with 0.8 % carboxy 
methyl cellulose (EMD Millipore), 100 U/ml penicillin-streptomycin (Gibco) and 2% FBS  
was added to the infected BHK-21 cells. The plates were incubated in the CO2 incubator at 
37°C for 5 days, to progress the infection into cytopathic with the formation of plaques. At 
the end of incubation, the cells were fixed in 3% paraformaldehyde for 30 minutes and 
washed with tap water. The fixed cellular layer in the wells was stained with 1% crystal 
violet solution for 20 minutes. Excess stain was removed with tap water washing and the 
plates were dried. The number of unstained translucent plaques in the background of crystal 
violet stained cells indicated the number of infectious DENV2 particles present in the diluted 
samples. The numbers of plaques were converted to plaque forming units per ml of 
experimental samples using the equation given below. Virus titer (pfu/ml) = average number of 
plaques/200µl inoculum x 1,000 µl x dilution factor. 
3. Results 
3.1 Confirmation of In-Vitro Transcribed RNA (IVT-RNA) 
 The pRS424 plasmid containing the sub-genomic DENV2 replicon was linearized with 
SacI Restriction Enzyme (RE) and separated on an agarose gel (supplementary Fig.1A). A 
single linear DNA band was observed upon RE digestion. The purified linear DNA 
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(supplementary Fig.1B) was used as a template for in vitro RNA synthesis as described in the 
Methods. The IVT- RNA was separated and analyzed by agarose gel electrophoresis 
(supplementary Fig.1C).The purified IVT-RNA was transfected into naïve BHK-21 cells. 
The stable cells were selected by G418 antibiotic selection as detailed in Methods.  
3.2 MPA treatment shows minimal cytotoxicity on stable BHK-21/DENV2 replicon cells 
 In vitro cytotoxicity of MPA on stable BHK-21/DENV2 replicon cells was examined 
by MTT assay. The optimum concentration (IC50 of  MPA=3.8 µM) was calculated as 
shown in the standard dose response curve (supplementary Fig.5).Based on MTT cytotoxicity 
assay, a sub-lethal dose of  1.25µM  MPA was used for further analysis. The microscopic 
observation indicates that stable BHK-21/DENV2 replicon cells treated with 1.25µM MPA 
were morphologically similar to the untreated stable BHK-21/DENV2 replicon cells 
(supplementary Fig.2). The cell viability was found to be 90% in the untreated stable BHK-
21/DENV2 cells, whereas 82% cells were viable in the MPA-treated stable BHK-21/DENV2 
cells by MTT assay. 
3.3 Stable BHK-21/DENV2 replicon cells show the expression of DENV2- NS4A 
The replication of DENV2 -RNA in stable BHK-21/DENV2 replicon cells was 
confirmed by the presence of DENV2 –NS 4A gene expression (supplementary Fig.3). The 
PCR amplified product of DENV2- NS4A gene corresponding to the band size of 855 bp in a 
2% agarose gel indicates that there is an active replication of DENV2-RNA in the stable 
BHK-21/DENV2 replicon cells.  
3.4 MPA treatment inhibits DENV2-RNA replication as evidenced by reduction in Renilla 
Luciferase (RLuc) enzyme activity in cell lysates  
The effect of 1.25 µM  MPA treatment (24 hours) on DENV2-RNA replication was 
assessed in stable BHK-21/DENV2 replicon cells by measuring RLuc enzyme activity. The 
addition of  MPA to stable BHK-21/DENV2 replicon cells showed a significant reduction in 
Rluc activity (RLU) as compared to the untreated  stable BHK-21/DENV2 replicon cells as 
represented in Fig.1. The value of p<0.05 is statistically significant.  
3.5 MPA treatment inhibits DENV2- NS1 protein secretion into cell culture supernatants 
The semi-quantitative estimation of DENV2-NS1 protein in the culture supernatant of 
stable BHK-21/DENV2 replicon cells and the effect of 1.25µM MPA (24 hours) on its 
secretion was carried out by NS1 capture ELISA. The secretion of  DENV2 -NS1 protein into 
the stable BHK-21/DENV2 replicon  cell culture media was significantly  reduced to 65% 
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upon treatment with 1.25µM  MPA in stable BHK-21/DENV2 replicon cells as compared to 
the untreated cells (Fig. 2). The value of p<0.05 is statistically significant.  
3.6 MPA treatment alters the expression of ATGs in stable BHK-21/DENV2 replicon cells 
3.6.1 Multi-gene expression analysis shows over-expression of initial autophagy genes in 
stable BHK-21/DENV2 replicon cells 
Based on the above observation, further analysis was carried out to quantify the ATG 
expression at the transcriptional level in the stable BHK-21/DENV2 replicon cells treated 
with 1.25µM MPA for 24 hours.  Total RNA was extracted from MPA treated stable BHK-
21/DENV2 cells,  untreated cells and control cells (Naïve BHK-21). As shown in 
supplementary data (Excel sheet), the average threshold values (Ct) of all the ATGs obtained 
from the above three sets of untreated stable BHK-21/DENV2 replicon cells (Group 1),  
MPA-treated stable BHK-21/DENV2 replicon cells (Group 2) and naïve BHK-21cells were 
calculated. The relative expression level of the autophagy genes, which met the criteria of 
greater than 2-fold change was taken into consideration. The difference in the melt curves of 
autophagy genes represents the specificity of qRT-PCR amplified products. 
The differential autophagy gene expression is represented by difference in color of heat maps 
(Fig. 3), which provides a visualization of the fold changes in gene expression in the context 
of the PCR array layout. Also, the differential expression of normalized autophagy-associated 
genes in stable BHK-21/DENV2 replicon cells (Group 1) and MPA-treated BHK-21/DENV2 
replicon cells (Group 2) are given in scatter plots (Fig. 4). 
In the RT2 profiler, the expression of four genes, Unc-51 like kinase 2 (ULK2) (fold 
change = 2.62), Cathepsin D (CTSD) (fold change = 2.07), Trans-membrane protein (TMEM 
74) (fold change = 7.32) and Estrogen receptor protein 1 (ESR1) (fold change = 3.32) were 
significantly higher in stable BHK-21/DENV2replicon cells (Group 1) as shown in Fig. 8. It 
is known that proteins encoded by the above genes play a functional role in the initial 
induction of autophagy by the formation of pre-autophagosmal structures.  
3.6.2 Multi-gene expression analysis shows downregulation of initial autophagy genes in 
stable BHK-21/DENV2 replicon cells upon MPA treatment: Next, we investigated the effect 
of MPA treatment on initial autophagy inducing genes which were seen upregulated in the 
stable BHK-21/DENV2replicon cells. The multi-gene analysis (Fig. 5) showed a 
downregulation of ULK2, CTSD, TMEM 74 and ESR1 autophagy genes in MPA treated 
stable BHK-21/DENV2 replicon cells (Fig. 5B) as compared to untreated stable BHK-
21/DENV2 replicon cells (Fig. 5A). This result also indicates that the over-expression of 
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autophagy initiator genes is dependent on the replication of dengue viral RNA in the stable 
BHK-2/DENV2 replicon cells (Fig. 6). 
3.6.3 Cysteine protease coding genes were upregulated in stable BHK-21/DENV2replicon 
cells upon MPA treatment 
The up-regulation of  ATG4A, ATG4B and ATG4C  genes which code for cysteine proteases 
in MPA treated stable BHK-21 /DENV2 replicon cells suggests that the MPA treatment  
activates cysteine proteases in stable BHK-21 /DENV2 replicon cells. These cysteine 
proteases are involved in the de conjugation of lapidated LC3 (LC3II). In addition, AKT1, 
APP, ATG16L1, ATG16L2, B2M and HPRT1 genes were also upregulated in stable BHK-21 
/DENV2 replicon cells upon MPA treatment (Fig.5). Overall, the expression of 10 % (10/84) 
of ATG genes were up-regulated greater than 2-fold in MPA treated stable BHK-21/DENV2 
replicon cells (Group 2) in RT2 Profiler PCR Array (Fig. 4).  
3.6.4  MPA treatment reduces LC3 lipidation (LC3 II )as well as p62 (SQSTM1)levels 
         The measurement of LC3II and p62 protein levels are indicative substrates for the 
autophagic degradation and can be used to monitor autophagic flux. LC3 II is associated with 
the inner and outer membrane of autophagosomes whereas p62 binds to both ubiquitinated 
proteins and LC3. There was a reduction in LC3 II and p62 expression in the stable BHK-
21/DENV2 replicon cells  after MPA treatment as compared to the untreated cells (Fig.7),  
indicating the degradation of autophagic substrates in autolysosomes. It is noteworthy that 
stable BHK-21/DENV2 replicon cells harboring sustained replication of DENV2 subgenome 
showed an accumulation of  LC3II as well as p62 proteins. This observation further indicates 
an important role of these proteins for the effective replication of the DENV2 subgenome 
without undergoing the fusion and degradation. 
3.6.5 MPA inhibits DENV2  multiplication  
The treatment of MPA with DENV2 infected BHK-21 cells as detailed in the methods 
(2.6.1), showed significant inhibition of dengue virus titer in the cell culture supernatant as 
compared to untreated BHK-21 cells.  The analysis revealed that MPA treated BHK-21 cells 
exhibited 99-100 % clearance of infection at concentrations greater than 1.25 µM MPA (n=3) 
at an MOI of 1. The control treatment (DMSO, 1 MOI) had 2.75 X 105 PFU/ mL of DENV2 
infectious particles, whereas when treated with 1.25 µM concentration of MPA, the number 
of infectious particles were reduced to 2000 PFU/mL. Dose-response curves of MPA 
treatment versus % DENV2 inhibition demonstrated that there was 99.9% of DENV2 
inhibition at 1.25µM MPA. An exponential fit of the log [drug concentration] versus DENV2 
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infectious particles per various dosage treatments (Fig.8) showed that 0.293 µM MPA can 
inhibit 50% of infection (EC50). 
4. Discussion 
The proviral and/or antiviral role of cellular autophagy within the infected cells vary 
depending on the viral tropism (8,18,19, 20). Accumulating evidence suggests that DENV 
infection induces autophagy vesicles, which aid in the viral replication and protect from the 
host immune system (21). The effective role of antiviral drugs such as MPA on DENV 
inhibition is poorly studied. In the present study, the stable BHK-21/DENV2 replicon cells 
were generated which exhibited notable autophagy gene expression changes induced by sub-
genomic DENV2 replicon RNA. The present data provides an interesting insight into 
autophagy induction in these cells and the inhibitory effect of MPA on it. Furthermore, in the 
stable BHK-21/DENV2 replicon cells, dengue viral subgenomic DENV2 RNA  is expressed 
at levels similar to the cells infected with DENV2 (NGC strain) RNA (14). The presence of 
DENV2-NS4A gene amplification in stable BHK-21/DENV2 replicon cells indicates the 
effective DENV2 -RNA replication in stable BHK-21/DENV2 replicon cells. Understanding 
dengue viral inhibition as well as activation of host genes and their coordination by cell 
signaling processes in presence of viral inhibitors is an attractive strategy to design antiviral 
drug analogues to curb DENV infection. There is a paucity of literature to specify the action 
of MPA in dengue viral replication. 
In this context, the effect of MPA was tested on the stable BHK-21/DENV2 replicon cells 
and the expression of p62 and LC3II substrates involved in autophagosome degradation.  
Additionally,  autophagy gene expression under the influence of MPA was analyzed in stable 
BHK-21/DENV2 replicon cells. The drug concentration of  MPA for treating stable BHK-
21/DENV2 replicon cells  was selected  based on EC50 value of dose response curve 
(supplementary Fig 5) in MTT assay. The recombinant plasmid pRS424/DENV2 replicon 
construct contains Renilla luciferase gene upstream of DENV2 nonstructural genes under the 
control IRES. Therefore, expression of luciferase enzyme activity is directly proportional to 
the replication/translation of DENV2 sub-genome in stable BHK-21 /DENV2 replicon cells. 
Upon treatment of stable BHK-21/DENV2 replicon cells with MPA showed a significant 
decrease in the Luciferase enzyme activity indicating the inhibition of DENV2 RNA 
replication/translation. Similarly, the treatment of MPA reduced the level of DENV2-NS1 
protein in the cell culture supernatant of stable BHK-21 /DENV2, supporting the 
aforementioned decrease in the luciferase activity. These observations, further suggests that 
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MPA may transiently halt the replication process without effecting the cell viability of the 
stable BHK-2/DENV2 replicon cells.  
We noted a significant alteration in host autophagy gene expression after the MPA treatment 
of stable BHK- 21 /DENV2 replicon cells. Such a change in gene expression pattern provides 
critical, cumulative information on the functional role of autophagy flux under stress 
conditions, which often correlates with DENV replication in the infected host cells.  The 
relative autophagy gene expression profile in vitro observed here offers some interesting cues 
as to how dengue virus replication might be affecting this process in vivo and also how 
DENV is hijacking the host translation machinery and multiplying  in the infected cells. In 
Hepatitis C virus (HCV), autophagy helps in the initial gene translation but not in the 
maintenance of viral replication (19). The Measles virus induces the earlier event of 
autophagy by binding to the cell surface receptor CD46 facilitating its viral entry (18). There 
is also evidence, which suggests that unlike enteroviruses, DENV infection depends on host 
machinery for making dengue viral envelope proteins via lipophagy, an autophagy dependent 
process activated in replication of DENV (22).  
In the present study, we noted upregulation of ULK2, CTSD, ESR1 and TMEM74 expression 
in the stable BHK-21/DENV2 replicon cells with actively replicating sub-genomic DENV2- 
RNA. These genes were downregulated in the post MPA treatment. Based on our results, it is 
conceivable that these genes play a major role in dengue virus replication via activating initial 
autophagy machinery leading to formation of pre-autophagosomal structure (PAS), which 
gets halted upon the MPA treatment. To the best of our knowledge, this is the first report 
demonstrating relative autophagy gene expression profile in stable BHK-21/DENV2 replicon 
cells and the effect of MPA on it. The proteins encoded by the upregulated genes in stable 
BHK-21/DENV2 replicon cells perform important cellular functions in the autophagy 
induction process. The upregulated ULK2 gene is crucial for the autophagy initiation (23) 
and Cathepsin D (CTSD) is an important autophagy marker (5) in DENV replication. 
Inhibition of  CTSD impairs the autophagy flux and TMEM74 protein over-expression has a 
role in the autophagy cellular process (24). Also, TMEM 74 is involved in the initial stage of 
functional autophagosome formation (24).  
The MPA treatment shows an aberrant expression of ATGs in stable BHK-21/DENV2 
replicon cells including the upregulation of ATG4A, ATG4B, ATG4C, ATG4D, AKT1, 
APP, ATG16L1, ATG16L2, B2M and HPRT1 genes. The ATG4A, ATG4B and ATG4C 
code for Cysteine proteases involved in conjugation of  LC3 to LC3-PE (25) as well as de 
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conjugation of  LC3-PE to LC3 (26). These cysteine proteases, which are upregulated in 
MPA treated stable BHK-21/DENV2 cells are probably involved in deconjugation of LC3-
PE to LC3. The significant upregulation of HPRT1 gene expression observed here suggests 
the perturbation in purine nucleotide metabolism. It is reported that MPA inhibits IMPDH 
(Inosine Monophosphate Dehydrogenase) activity resulting in the depletion of GTP pool and 
inhibition of DENV replication (15). Therefore, the enhancement in the HPRT1 gene 
expression may induce a positive modulation of salvage pathway of purine metabolism. 
However, the replication could not be rescued, most likely due to downregulation of  the 
early phase autophagy genes, and upregulation of  cysteine protease coded by ATG genes. 
The increase in the expression of ULK2, CTSD, ESR1 and TMEM74 genes in stable BHK-
21/DENV2 replicon cells suggest that DENV2 replication depends on early phase of 
autophagosome formation which helps in DENV2 replication. In addition, our data are in 
accordance with the previous report by Philippe et al., (2015), where the virus induced an 
initial activation of autophagic flux during infection.  
There is decrease in LC3 II (lapidated LC3) and p62 (Sequestosome 1) protein expression  in 
MPA  treated stable BHK-21/DENV2 replicon cells in comparison to the untreated cells. LC3 
II and p62 are autophagy substrates and get degraded upon fusion of  autophagosome with  
lysosome (28). Therefore, it can be surmised that MPA inhibits DENV2 genome replication 
by promoting the degradation of autophagosome along with the enhancement of ATG4A 
gene expression resulting in the delipidation of  LC3II (28). Further, it was observed that 
MPA treatment suppresses ATGs involved in the PAS formation. It’s also noteworthy that 
MPA accelerates the autophagic degradation process as evidenced by the significant 
upregulation of HPRT1, an enzyme involved in the salvage  pathway of purine nucleotide. 
This observation is in agreement with an earlier study which showed that MPA inhibits de-
novo synthesis of guanine nucleotide by targeting IMPDH (IMP dehydrogenase) (29). In the 
in vitro system, DENV2 (NGC strain) multiplication was significantly reduced upon the 
treatment with MPA as indicated by the reduction in virus titer (plaque assay) in the DENV2 
infected BHK-21 cells. Our data shed light on DENV pathogenesis and prompt further 
investigation into the design of antiviral drug therapy with respect to the autophagy induction.  
 
5. Conclusion  
Current study highlights that MPA can effectively inhibit DENV2 subgenomic RNA 
replication and alter the autophagic degradation as evidenced by the decrease in p62 and 
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LC3II protein levels. Importantly, there was an upregulation of ATG4A gene expression 
which codes for cysteine protease involved in the delipidation of  LC3II. We also observed 
that MPA suppresses the ATGs responsible for the formation of PAS, which are found to be 
elevated during the sustained replication of DENV2 subgenomic RNA. Further, MPA was 
enhancing the expression of  HPRT1 gene indicating the possibility of utilizing salvage of 
purine nucleotides. Notably, the inhibitory effect of MPA in reducing the viral titer of 
DENV2 in the infected BHK-21 cells was clearly evident. Overall, our findings are of critical 
significance in understanding the molecular pathogenesis of dengue virus with respect to 
modulation of autophagy. Our study provides further impetus in designing new MPA 
analogues to effectively inhibit dengue viral replication and to a better understanding of host-
virus interactions.  
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CAPTIONS 
Figure.1. Mycophenolic Acid  (MPA) inhibits Renilla Luciferase (RLuc) enzyme 
activity in stable BHK-21/DENV2 replicon cells. Bar diagram showing RLuc 
enzyme activity of stable BHK-21/DENV2 replicon cells (untreated group) and 1.25 
µM MPA (24 hours) treated stable BHK-21/DENV2 replicon cells (treated group). 
The relative RLuc activity was analysed with unpaired Student’s t-test (two-tailed, 
unequal variance) and graphs were made using Graph Pad Prism software. version 
5.0. The data represent mean average value of three independent experiments (n=3) 
+Standard Deviation (p<0.05). In the bar graph,  X -axis represents the stable BHK-
21/DENV2 replicon cells +/- MPA and Y -axis represents RLuc enzyme units (RLU). 
 
Figure.2. Mycophenolic Acid  (MPA) decreases the quantity of the secreted NS1 
in stable BHK-21/DENV2 replicon cells.  Histograms showing DENV2-NS1  
protein secretion from stable BHK -21/DENV2 replicon cells (untreated group) and 
1.25 µM MPA (24 hours) treated stable BHK -21/DENV2 replicon cells (treated 
group).The optical densities (O.D) were measured spectophotometerically at 450 nm.  
The data were analyzed with unpaired Student’s t-test . The bar diagram was made 
using Graphpad Prism software version 5.0. The values p < 0.05 were statistically 
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significant. In the bar graph X -axis represents stable BHK-21/DENV2 replicon cells 
+/- MPA  and Y -axis represents the O.D at 450 nm measured by ELISA. 
 
Figure.3. Heat maps showing differential  expression of autophagy-associated 
genes. Based on analysis of  RT2 Profiler PCR array, heat maps show differential 
expression of autophagy-associated genes in three groups (A, B and C). (A) Group 1 
versus Control (B) Group 2 versus Control (C) Group 1 versus  Group 2.  The fold 
change greater than 2 is highlighted in red, less than 2 is in green and  unchanged 
genes in black. The heat map represents a visualization of the fold changes in  the 
context of the array layout. Stable BHK-21/DENV2 replicon cells (Group 1), BHK-
21/DENV2 replicon cells treated with MPA (1.25µM) for 24 hours (Group 2) 
normalized with control group (naïve BHK-21 cells).   
 
Figure.4. Scatter plots showing the differential expression of autophagy-
associated genes.  (A) Group 1 versus control group; (B) Group 2 versus control 
group; (C) Group 1 versus Group 2. Based on analysis of RT2 Profiler PCR array, 
scatter plots  displayed differential expression of autophagy-associated genes in three 
groups (A,B and C) with fold change  greater than 2.The red arrow indicates gene 
upregulation and blue arrow indicates downregulation. Upregulated genes greater than 
2 were highlighted in brown, downregulated less than 2 were in green and unchanged 
genes in black. Stable BHK-21/DENV2 replicon cells (Group 1), stable BHK-
21/DENV2 replicon cells treated with 1.25 µM MPA for 24 hours (Group 2)  and 
control  group (naïve BHK -21cells).  
 
Figure.5. Multi gene analysis displaying the relative autophagy gene expression 
levels.  (A) Increased or decreased gene regulation in stable BHK-21/DENV2  
replicon  cells  (untreated group) (B) Altered gene expression in stable BHK 
21/DENV2 replicon cells treated with 1.25µM MPA for 24 hours (treated group). X-
axis indicates autophagy genes, Y-axis indicates fold change in gene expression.  The 
upregulated genes CTSD ( fold change 2.074), ESR1 (fold change 3.32), TMEM74 
(fold change 7.32) and ULK2 (fold change 2.62) are underlined  with red  colour in 
(A). The downregulated genes upon MPA treatment are underlined  with green colour 
in (B).  
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Figure.6.  A clustergram of the expression profile of autophagy genes.  Relative 
expression patterns of  autophagy-associated genes in stable  BHK -21/DENV2 
replicon  cells (Group1), 1.25 µM MPA (24 hours) treated BHK-21/DENV2 replicon 
cells (Group 2)  and  control group (naïve BHK-21), as shown in a clustergram  based 
on RT2 Profiler PCR array (PAHS-084Z). Expression clusters were indicated by color 
bars next to the genes and groups that were included in different clusters. The 
magnitude of gene expression scale is indicated at the bottom, which represents the 
gene relative expression levels by a range of colors. The clustergram represents 
hierarchical clustering of the entire co-regulated genes across the three groups.  
 
Figure.7. LC3 and p62 (Sequestosome 1) in MPA untreated/treated stable BHK-
21 /DENV2 replicon cell lysates. Stable BHK-21/DENV2 replicon cells were treated 
with (+) and without (-) 1.25 µM MPA (24 hours). Approximately 20 µg of protein 
was separated on a gel by 10 % SDS-PAGE, transferred to 0.45 um PVDF membrane 
and blocked in 5% BSA in TBST. The membranes were probed with 1:1000 dilution 
of  Rabbit anti-LC3 antibody (Thermo scientific; 710014), mouse anti-P62 
(Abcam;ab56416), and mouse anti β-actin (Thermo scientific ;MA5-15739) were 
detected with the appropriate secondary antibodies using chemiluminescent 
WesternBright ECL developer (Advansta ; K-12045-20). The band intensities of p62 
protein expression level (A) and LC3II (B) between MPA treated and untreated  
stable BHK-21/DENV2 replicon cells were carried out using Image studio software 
(LiCor,C-Digit scanner) and GraphPad Prism software version 5.0. Data from western 
blotting  were analyzed with unpaired Student’s t-test (two-tailed, unequal variance). 
For all analysis, values of p < 0.05 were considered statistically significant. 
 
Figure. 8. MPA inhibits DENV2 virus titer in the cells infected with DENV2 
(NGC strain).  
(A) BHK-21 cells were infected with 1 MOI of DENV2 (NGC strain) and subjected 
to the treatment of various concentrations of MPA ranging from 0.078 µM to 5 µM 
and incubated for 24 hours. DENV2 titers were measured in the cell culture 
supernatant in treated and untreated cells by plaque assay. The data is expressed in 
Plaque Forming Units (PFU) per ml.  
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(B) Dose response curve of MPA versus  virus yield in the cell culture supernatant of 
DENV2 (NGC strain) infected BHK-21 cells. X- axis represents concentration of 
MPA as Log (µM); Y-axis represents the percent inhibition of  DENV2 yield. MPA 
treatment inhibits 50% of infection (EC50) at the concentration of 0.293 µM.  
SUPPLEMENTARY CAPTIONS 
Supplementary Figure. 1. Synthesis of In vitro transcribed RNA (IVT-RNA). Two 
% agarose gel image showing  (A) p424 replicon plasmid in Lane 1  and SacI digested 
p424 replicon plasmid in Lane 2; (B) Purified Sac I digested plasmid in lane 1 and  
(C)  In vitro transcribed RNA in lane 1 and 1 Kb ladder in lane M.  
 
Supplementary Figure. 2. Bright field microscopic images of stable BHK-
21/DENV2 replicon cells  and 1.25 µM MPA treated BHK-21/DENV2 replicon 
cells.  Cell morphology was observed under a phase-contrast microscope (Leica DM 
3000, 10X magnification). (A) MPA treated  stable BHK-21/DENV2 replicon cells 
(B) stable  BHK-21/DENV2 replicon cells . Note that MPA treatment does not induce 
any morphological changes. The degree of magnification 600 pixel was indicated on 
the image.  
 
Supplementary Figure. 3. Amplification of DENV2-NS4A. Two %  agarose gel  
image showing  DENV2 -NS4A specific 855-bp  long DNA band amplified by RT-
PCR; Lane 1: Naive BHK-21 cells and Lane 2: Stable BHK- 21/DENV2 replicon 
cells, Lane 3 & 4: Beta actin specific PCR product (116-bp) of naïve BHK-21 cells 
and stable BHK-21/DENV2 replicon cells respectively. M: 100bp DNA ladder.  
 
Supplementary  4. RT2 profile of autophagy genes in a stable BHK-21/DENV2 
replicon cells and 1.25µM MPA (24 hours)  treated stable BHK-21/DENV2 replicon 
cells. 
 
Supplementary Figure. 5. MPA dose-response curves of treatments in MTT Assay. 
Standard plot for measuring in vitro toxicity of  mycophenolic acid (MPA ) 
compound on stable  BHK -21/DENV2 replicon cells by MTT  3-(4,5-
dimethylthiazol-2-yl)-2,5 –diphenyl tetrazolium bromide) assay. The  stable BHK -
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21/DENV2 replicon cells  were treated at  various concentration of MPA  for 24 hours 
. The EC 50 values of MPA  was estimated at 3.8 µM.  
 
 
 
Highlights 
• Due to unavailability of a preventive vaccine, Dengue virus infection urgently needs 
effective antiviral therapy capable of preventing virus replication. 
• Stable BHK-21/DENV2 replicon cells are ideal in vitro model to understand the viral 
replication and inhibition. 
• Dengue viruses exploit the host cell autophagy machinery for its successful 
replication. 
• MPA has potential to block dengue viral replication, however the actual targets are 
not known. 
• MPA inhibits the initial phase of autophagy machinery involved in dengue viral 
replication. 
• The findings warrant the development of broad spectrum antiviral medications or 
MPA analogues to curb infectious dengue viruses. 
 
 
 
 
 
 
 
 








